ArticleAdvances in neurodevelopmental disorders2024
Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in ADHD: A Systematic Scoping Review.
Article in Advances in neurodevelopmental disorders, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Kynurenine metabolites unchanged after multinutrient supplementation in children with ADHD: a secondary data analysis from the MADDY study.Journal of neural transmission (Vienna, Austria : 1996) · 2026Trial
- Urinary Histamine Not Associated with Severity of Symptoms of ADHD and Emotional Dysregulation: A Cross-sectional Secondary Data Analysis from the Micronutrients for ADHD in Youth (MADDY) Study.Advances in neurodevelopmental disorders · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Objectives: Neutrophil-lymphocyte and platelet-lymphocyte ratio (NLR, PLR) are easily calculated from routine blood tests and are increasingly being used in research to assess disease severity in inflammatory, infectious, and psychiatric conditions. The goal of this systematic scoping review was to broadly examine the literature on NLR and PLR and attention-deficit/hyperactivity disorder (ADHD). Methods: The PubMed/Medline, PsychInfo, Scopus, Embase, Cochrane Central Register of Controlled Trials, Cumulative Index to Nursing and Allied Health Literature, ClinicalTrials.gov, World Health Organization International Clinical Trials Registry Platform, International Standard Randomized Controlled Trial Number, Google Scholar, Directory of Open Access Journals, and ProQuest databases were searched. Results: Among the 1542 articles evaluated, 15 were included. Fourteen studies evaluated children and adolescents with ADHD and one study evaluated adults. Study outcomes included the comparison of mean NLR and PLR values between ADHD and non-ADHD groups and the association of NLR and PLR values with measures of ADHD symptom severity. Four studies used receiver operating characteristic (ROC) curves to identify potential cut points for the diagnosis of ADHD. Assessing NLR and PLR is economical and minimally invasive. Conclusions: Based on the 15 studies reviewed, findings suggest NLR and PLR may be promising biomarkers for ADHD. Additional research is justified to further investigate if routine incorporation of NLR and PLR into research and clinical practice could beneficially impact the diagnosis and treatment of patients with ADHD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.